A Phase I/Ii Trial of TLR-7 Agonist Immunotherapy in Chronic Lymphocytic Leukemia

Leukemia - United Kingdom
doi 10.1038/leu.2009.195
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC